Activation of IFIH1 (also known as MDA5) in tumors has been identified to facilitate re‐activation of tumor‐specific T cells which are otherwise functionally defective within the TME and to impede tumor‐induced immunosuppression in an IFN‐dependent manner.44, 45. Here, IFIH1 is linked to neoplasm.